Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
H R Gralnick, … , B S Coller, Y Sultan
H R Gralnick, … , B S Coller, Y Sultan
Published October 1, 1975
Citation Information: J Clin Invest. 1975;56(4):814-827. https://doi.org/10.1172/JCI108160.
View: Text | PDF
Research Article

Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.

  • Text
  • PDF
Abstract

The Factor VIII/von Willebrand factor protein was characterized in two unrelated patients with von Willebrand's disease in whom procoagulant and Factor VIII/von Willebrand factor antigen levels were normal. In both patients evidence of an abnormal protein was observed on crossed antigen-antibody electrophoresis. In one patient the Factor VIII/von Willebrand factor protein eluted from Sepharose 4B in a position and distribution identical to normal with normal levels of procoagulant activity and antigen. However, the partially purified Factor VIII/von Willebrand factor protein had markedly reduced von Willebrand factor activity in a ristocetin assay. In the second patient the peak of Factor VIII/von Willebrand factor protein, antigen, and procoagulant activity eluted from a Sepharose 4B column with an estimated molecular weight of approximately half that of normal. This protein had no von Willebrand factor activity. In both patients the reduced Factor VIII/von Willebrand factor protein subunit was indistinguishable from normal on polyacrylamide gel electrophoresis. These studies indicate that in some patients with von Willebrand's disease there is a qualitative defect of the Factor VII/von Willebrand factor protein; the total amount of protein, antigen, and procoagulant activity are normal while the von Willebrand factor activity is deficient.

Authors

H R Gralnick, B S Coller, Y Sultan

×

Total citations by year

Year: 2021 2019 2014 2009 2006 2004 1998 1995 1991 1990 1989 1988 1987 1985 1984 1983 1982 1981 1980 1979 1978 1977 1976 Total
Citations: 1 1 1 1 1 1 1 1 2 2 1 1 4 4 3 2 3 2 5 3 6 11 5 62
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (62)

Title and authors Publication Year
Obituary Harvey R. Gralnick, MD (1937–2020)
BS Coller, RJ Hirschman
Journal of Thrombosis and Haemostasis 2021
Endothelial Activation Markers as Disease Activity and Damage Measures in Juvenile Dermatomyositis
T Kishi, J Chipman, M Evereklian, K Nghiem, M Stetler-Stevenson, ME Rick, M Centola, FW Miller, LG Rider
The Journal of rheumatology 2019
The platelet: life on the razor's edge between hemorrhage and thrombosis: PLATETLETS IN HEMOSTASIS AND THROMBOSIS
BS Coller
Transfusion 2014
IN MEMORY OF ERIK JORPES
IM Nilsson
Scandinavian Journal of Haematology 2009
Characterization of Recessive Severe Type 1 and 3 von Willebrand Disease (VWD), Asymptomatic Heterozygous Carriers Versus Bloodgroup O-Related von Willebrand Factor Deficiency, and Dominant Type 1 VWD
JJ Michiels, Z Berneman, A Gadisseur, M der Planken, W Schroyens, A de Velde, H Vliet
Clinical and Applied Thrombosis/Hemostasis 2006
Biography of Barry S. Coller
C Brownlee
Proceedings of the National Academy of Sciences 2004
Platelet von Willebrand factor in Hermansky-Pudlak syndrome
LP McKeown, KE Hansmann, O Wilson, W Gahl, HR Gralnick, KE Rosenfeld, SJ Rosenfeld, MD Horne, ME Rick
American Journal of Hematology 1998
Activated platelets in paroxysmal nocturnal haemoglobinuria
HR Gralnick, M Vail, LP McKeown, P Merryman, O Wilson, I Chu, J Kimball
British Journal of Haematology 1995
Platelet activation and alpha granule secretion in type IIB von Willebrand's disease
HR Gralnick, S Williams, LP McKeown, G Connaghan, B Shafer, K Hansmann, L Magruder, M Vail
British Journal of Haematology 1991
Prolonged bleeding time due to mitotane therapy
HR Haak, KM Caekebeke-Peerlinck, AP van Seters, E Briët
European Journal of Cancer and Clinical Oncology 1991
An infrequent DNA polymorphism associated with severe von Willebrand's disease
KM Caekebeke-Peerlinck, E Bakker, E Briet
British Journal of Haematology 1990
Critical role of the carbohydrate moiety in human von Willebrand factor protein for interactions with type I collagen
CM Kessler, CM Floyd, SC Frantz, C Orthner
Thrombosis Research 1990
Bleeding time, blood groups and von Willebrand factor
KM Caekebeke-Peerlinck, T Koster, E Briët
British Journal of Haematology 1989
Genetic linkage of two intragenic restriction fragment length polymorphisms with von Willebrand's disease type IIA. Evidence for a defect in the von Willebrand factor gene
CL Verweij, R Quadt, E Briët, K Dubbeldam, GB van Ommen, H Pannekoek
Journal of Clinical Investigation 1988
HYPOTHYROIDISM AS A CAUSE OF ACQUIRED VON WDLLEBRAND'S DISEASE
RG Dalton, GF Savidge, KB Matthews, MS Dewar, PB Kernoff, M Greaves, FE Preston
The Lancet 1987
A variant of type II von willebrand disease with an abnormal triplet structure and discordant effects of protease inhibitors on plasma and platelet von willebrand factor structure
HR Gralnick, SB Williams, LP McCkeown, P Maisonneuve, C Jenneau, Y Sultan
American Journal of Hematology 1987
von Willebrand disease
TS Zimmerman, ZM Ruggeri
Human Pathology 1987
Effect of fish oil concentrates on hemorheological and hemostatic aspects of diabetes mellitus: A preliminary study
ME Miller, AA Anagnostou, B Ley, P Marshall, M Steiner
Thrombosis Research 1987
Substructure of human von Willebrand factor
WE Fowler, LJ Fretto, KK Hamilton, HP Erickson, PA McKee
Journal of Clinical Investigation 1985
Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor
HR Grainick, SB Williams, LP McKeown, ME Rick, P Maisonneuve, C Jenneau, Y Sultan
Journal of Clinical Investigation 1985
IgA inhibitor to factor VIII/von Willebrand factor
HR Gralnick, MA Flaum, CM Kessler, H Zimbler, BS Coller
British Journal of Haematology 1985
Platelet von Willebrand factor: Comparison with plasma von Willebrand factor
HR Gralnick, SB Williams, LP McKeown, DM Krizek, BC Shafer, ME Rick
Thrombosis Research 1985
Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation
AB Federici, JH Elder, LD Marco, ZM Ruggeri, TS Zimmerman
Journal of Clinical Investigation 1984
IN MEMORY OF ERIK JORPES: von Willebrand's Disease from 1926-1983
IM Nilsson
Scandinavian Journal of Haematology 1984
Von Willebrand’s Disease: Clinical Picture, Diagnosis, and Treatment
EJ Bowie
Clinics in Laboratory Medicine 1984
Role of carbohydrate in multimeric structure of factor VIII/von Willebrand factor protein
HR Gralnick, SB Williams, ME Rick
Proceedings of the National Academy of Sciences 1983
Von Willebrand's Disease
TS Zimmerman, ZM Ruggeri
Clinics in Haematology 1983
Factor VIII-related antigen pre-peak on crossed immunoelectrophoresis: A non-random phenomenon
CH Miller, MW Hilgartner, RC Lestrange, GW McLaughlin
Thrombosis Research 1982
Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic Purpura
JL Moake, CK Rudy, JH Troll, MJ Weinstein, NM Colannino, J Azocar, RH Seder, SL Hong, D Deykin
New England Journal of Medicine 1982
Unresolved problems in Haemophilia
CD Forbes, GD Lowe
1982
New Methods in Coagulation
DA Triplett, JG Batsakis
Critical Reviews in Clinical Laboratory Sciences 1981
Influence of factor VIII/von Willebrand factor protein (F VIII/vWF) and F VIII/vWF-poor cryoprecipitate on post-ischemic microvascular reperfusion in the central nervous system
JM Hallenbeck, TW Furlow, HR Gralnick
Stroke; a journal of cerebral circulation 1981
Fibrinogen houston: A dysfibrinogen exhibiting defective fibrin monomer aggregation and α-chain cross-linkages
RS Weinger, C Rudy, JL Moake, CL Conlon, PL Cimo
American Journal of Hematology 1980
GENETIC CONTROL OF FACTOR VIII
JB Graham
The Lancet 1980
Studies on the pathophysiology and treatment of von willebrand's disease. IV. Mechanism of increased ristocetin-induced platelet aggregation in von willebrand's disease
H Takahashi
Thrombosis Research 1980
Structure - function relationship of factor VIII/von Willebrand factor. Application to the study of variant von willebrand's disease and cryosupernatant prepared from normal plasma
G Pietu, B Obert, MJ Larrieu, D Meyer
Thrombosis Research 1980
Verhandlungen der Deutschen Gesellschaft für innere Medizin
B Schlegel
1980
Gross Hematuria Associated with Sickle Cell Trait and Von Willebrand’S Disease
RS Weinger, GS Benson, S Villarreal
The Journal of Urology 1979
Variante des von Willebrand-J�rgens-Syndroms mit Ver�nderung des Faktor VIII/von Willebrand Faktor Proteins
K Hasler, D Bttcher, R Engelhardt
Blut Zeitschrift für die Gesamte Blutforschung 1979
Von Willebrand's Disease Today
IM Nilsson, L Holmberg
Clinics in Haematology 1979
Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity
HR Gralnick
Journal of Clinical Investigation 1978
A method for measuring plasma ristocetin cofactor activity—normal distribution and stability during storage
M Zuzel, IM Nilsson, M Åberg
Thrombosis Research 1978
“Variants” of von Willebrand's disease. Demonstration of a decreased antigenic reactivity by immunoradiometric assay
N Ardaillou, JP Girma, D Meyer, JM Lavergne, I Shoa'i, MJ Larrieu
Thrombosis Research 1978
Predominance of normal low molecular weight forms of factor VIII in “variant” von Willebrand's disease
JJ Sixma, J Over, BN Bouma, AL Bloom, IR Peake
Thrombosis Research 1978
84. Kongreß
B Schlegel
1978
Aortic valve replacement in von Willebrand's disease
PH Young, JD Bouhasin, HB Barner
The Journal of Thoracic and Cardiovascular Surgery 1978
Stabilization of Factor VIII in Plasma by the von Willebrand Factor STUDIES ON POSTTRANSFUSION AND DISSOCIATED FACTOR VIII AND IN PATIENTS WITH VON WILLEBRAND'S DISEASE
HJ Weiss, II Sussman, LW Hoyer
Journal of Clinical Investigation 1977
Spectrum of von Willebrand's Disease: a Study of 100 Cases
PM Mannucci
British Journal of Haematology 1977
Heterogeneity of von Willebrand's disease: Study of 40 Iranian Cases
I Shoa'i, JM Lavergne, N Ardaillou, B Obert, F Ala, D Meyer
British Journal of Haematology 1977
Von Willebrand's Disease-Fifty Years Old
IM Nilsson
Acta Medica Scandinavica 1977
Von Willebrand's disease associated with thrombocytopenia and a fast migrating factor VIII related antigen
GE Rivard, MB Daviault, N Brault, L D'Aragon, R Raymond
Thrombosis Research 1977
Factor VIII related antigen in platelets of patients with Von Willebrand's disease
Y Sultan, BN Bouma, S Graaf, J Simeon, JP Caen, JJ Sixma
Thrombosis Research 1977
von Willebrand's disease: Current concepts
D Green, JR Chediak
The American Journal of Medicine 1977
Von Willebrand's Disease: Combined Qualitative and Quantitative Abnormalities
HR Gralnick, Y Sultan, BS Coller
New England Journal of Medicine 1977
Modification of factor VIII complex properties in patients with liver disease
P Maisonneuve, Y Sultan
Journal of clinical pathology 1977
The Year in Hematology
AS Gordon, R Silber, J LoBue
1977
Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein
JM Sodetz, SV Pizzo, PA McKee
The Journal of biological chemistry 1977
MOLECULAR DEFECTS IN HÆMOPHILIA A AND VON WILLEBRAND'S DISEASE
HR Gralnick, BS Coller
The Lancet 1976
ENDOTHELIAL CELLS AND FACTOR-VIII-RELATED PROTEIN
AL Bloom, IR Peake, JC Giddings, SA Shearn, EG Tuddenha
The Lancet 1976
COLD AND TIC DOULOUREUX
N Fitch
The Lancet 1976
Carbohydrate Deficiency of the Factor VIII/von Willebrand Factor Protein in von Willebrand's Disease Variants
HR Gralnick, BS Coller, Y Sultan
Science 1976
[Von Willebrand-Jürgens syndrome with a variant of factor VIII-associated antigen].
Böttcher D, Hasler K, Sutor AH, Mair D
Blut 1976

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts